Literature DB >> 12134112

Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet.

Mario Luppi1, Patrizia Barozzi, Valeria Rasini, Giovanni Riva, Alessandro Re, Giuseppe Rossi, Gisella Setti, Silvio Sandrini, Fabio Facchetti, Giuseppe Torelli.   

Abstract

We report the occurrence of human herpesvirus (HHV)-8 primary infection in an adult male kidney recipient. Four months after transplantation, the patient developed visceral Kaposi sarcoma, and 1 month later he presented with progressive and severe peripheral cytopenia, in the presence of a normocellular or hypercellular bone marrow (BM) with hemophagocytosis. HHV-8 was the sole pathogen detected by polymerase chain reaction either in the serum or in the BM. HHV-8 latent nuclear antigen was detected in immature progenitor cells from the BM. Immunosuppressive therapy was reduced, and the patient was treated with foscarnet for 2 weeks, leading to a dramatic normalization of blood cell counts, concomitantly with the disappearance of HHV-8 viremia. At the end of antiviral therapy, the patient received chemotherapy, and Kaposi sarcoma regressed in 2 months. Severe peripheral cytopenia may be a posttransplant complication after HHV-8 infection, for which treatment with foscarnet seems appropriate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134112     DOI: 10.1097/00007890-200207150-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  HHV-8-associated haemophagocytic lymphohistiocytosis in a patient with advanced AIDS.

Authors:  Saroja Bangaru; Amanda Strickland; Dominick Cavuoti; Nainesh Shah
Journal:  BMJ Case Rep       Date:  2017-12-22

3.  Recurrent Classical Type of Kaposi's Sarcoma Treated by Interferon-alpha.

Authors:  Min Ju Kang; Tae Yoon Kim
Journal:  Ann Dermatol       Date:  2008-09-30       Impact factor: 1.444

Review 4.  Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.

Authors:  Soren Gantt; Corey Casper
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

5.  Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8.

Authors:  William J Grossman; Mohammed Radhi; Dennis Schauer; Erick Gerday; Charles Grose; Frederick D Goldman
Journal:  Blood       Date:  2005-04-19       Impact factor: 22.113

Review 6.  [Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma].

Authors:  C Lebbé
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

7.  Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.

Authors:  Osama Gheith; Adel Bakr; Ehab Wafa; Ashraf Fouda; Amgad El Agroudy; Ayman Refaie; Ahmed Donia; Alaa Sabry; Mohamed Sobh; Ahmed Shokeir; Mohamed Ghoneim
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

8.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

9.  Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.

Authors:  Christopher H Parsons; Barbara Szomju; Dean H Kedes
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

10.  Successful treatment with liposomal doxorubicin for widespread Kaposi's sarcoma and human herpesvirus-8 related severe hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome.

Authors:  Shima Uneda; Shogo Murata; Takashi Sonoki; Hiroshi Matsuoka; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2009-01-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.